Trilogy Capital’s Vanguard Intermediate-Term Bond ETF BIV Stock Holding History
Bought
Maintained
Sold
Other funds holding BIV
EWA
TLFA
Trilogy Capital's BIV Position: Q2 2026 in Review
Trilogy Capital increased its Vanguard Intermediate-Term Bond ETF (BIV) stake by 1.1% in Q2 2026, buying an estimated $4.45K and bringing the position to 5,362 shares worth $411K. The position accounts for 0.02% of the portfolio, ranked #291.
Trilogy Capital first reported a position in BIV in Q1 2018 and has held it in 25 quarters since. The position peaked at $7.21M in Q3 2022. 1,017 funds tracked by Wall St. Rank hold BIV as of Q2 2026.
- Trilogy Capital held 5,362 shares of Vanguard Intermediate-Term Bond ETF worth $411K as of Q2 2026.
- Trilogy Capital bought 58 Vanguard Intermediate-Term Bond ETF shares in Q2 2026, an estimated $4.45K.
- Vanguard Intermediate-Term Bond ETF made up 0.02% of Trilogy Capital's portfolio in Q2 2026, its #291 holding.
- Trilogy Capital first reported a position in Vanguard Intermediate-Term Bond ETF in Q1 2018 and has held it in 25 quarters since.
- Trilogy Capital's Vanguard Intermediate-Term Bond ETF position peaked at $7.21M in Q3 2022.
- 1,017 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Bond ETF as of Q2 2026.
Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.